Price Prediction
ARM Price Prediction: Oversold on the tape, but analyst cuts and earnings strength point in different directions
Arm Holdings Tokenized Stock is trading at $171.67, down 1.26% on the day, after a sharp reset that has pulled the tokenized instrument below its short- and medium-term moving averages. The underly...
Market analysis includes conditional scenarios, not assured price outcomes or investment advice. Check the data, assumptions and dates cited.
Earnings backstop, but the market has already repriced the stock
Arm’s underlying business just posted a strong quarter: on November 4, the company said fiscal Q2 revenue reached a record $1.44 billion, up 27% year over year, marking the fifth consecutive quarter of total revenue growth above 20%. Management highlighted licensing and other revenue of $773 million, up 50% year over year, as a key driver. That matters because the operating print remains constructive even as the share price has de-rated hard.
But the market reaction has been different. The tokenized ARM instrument is changing hands at $171.67, well below its 7-day SMA of $178.98, its 20-day SMA of $201.71 and its 50-day SMA of $249.22. The structure says the recent trend is still under pressure even after a strong fundamental update.
Analyst targets were cut, not collapsed
On November 5, JP Morgan kept an Overweight rating and reduced its target to $245 from $255. TD Cowen cut its target to $250 from $350 while keeping Buy, Wells Fargo lowered its target to $255 from $280 and maintained Overweight, and RBC reduced its target to $300 from $340 and kept Outperform. Those revisions point to valuation compression rather than a thesis break.
The targets still sit above the current price, but the range is telling: the market is no longer paying for the same multiple as before. Wells Fargo explicitly cited broader semiconductor valuation pressure, while TD Cowen pointed to Arm’s progress on procurement and supply chain issues for its AGI CPU product and raised its first-year revenue expectation for that product to around $2 billion from an initial $1 billion goal.
Technical damage is real, but the stock is stretched
The daily RSI is 29.99, which places ARM in oversold territory, while the stochastic readings are also weak at 11.80 for %K and 9.44 for %D. MACD is negative at -20.0749, and the histogram is flat at 0.0000, so momentum has deteriorated without yet showing a clean reversal.
Price is sitting just above the lower Bollinger Band at $161.67, with %B at 0.1248, which means the instrument is pressing into the lower end of its recent range rather than reclaiming it. The 24-hour range of $177.11 to $166.48 shows the market is still trading with elevated volatility around the current pivot of $171.75.
Binance derivatives positioning is leaning long, but not decisively
On Binance Futures, funding is neutral at 0.0000%, so the contract is not paying a persistent premium to one side. Open interest stands at 20,058.92 contracts, with daily open interest value at $3.38 million and a 24-hour decline of 4.86%, which suggests some leverage has come out of the market.
Positioning ratios lean long: global accounts are 74.8% long versus 25.2% short, and top-trader accounts are 81.3% long versus 18.6% short. That shows Binance cohorts are tilted to the long side, but it does not by itself tell you whether the move will reverse immediately. Taker flow is close to balanced, with a 1-hour buy/sell ratio of 0.9720, so the order book is not delivering a strong directional signal right now.
Key levels that matter from here
Immediate support is $166.40, with strong support at $161.12. Resistance sits at $177.03 first, then $182.38. A clean move back above the 7-day average and immediate resistance would be the first sign that the recent washout is stabilizing; failure to hold the $166 area keeps the lower-band test in play.
For now, ARM is caught between a better-than-expected underlying earnings print and a market that has aggressively compressed valuation. The next move will likely depend on whether buyers can defend support before the oversold condition fades.